By 2030, Quality in Life Sciences will transform into a catalyst for amplifying value. By infusing quality throughout the enterprise, organisations can create offerings that align with customer needs, lower compliance risk, and fuel continuous improvement. There are so many opportunities for quality to become a competitive advantage that Quality transformation should be on the boardroom agenda for years to come.
How can CXOs take their organisations there?
By bringing quality inside.